Fung-Tomc J - Search Results

1

Susceptibility of bacterial isolates to gatifloxacin and ciprofloxacin from clinical trials 1997-1998.

Huczko E, Conetta B, Bonner D, Valera L, Stickle T, Macko A, Fung-Tomc J. Huczko E, et al. Int J Antimicrob Agents. 2000 Dec;16(4):401-5. doi: 10.1016/s0924-8579(00)00223-5. Int J Antimicrob Agents. 2000. PMID: 11118848

2

In vitro and in vivo activities of a novel cephalosporin, BMS-247243, against organisms other than staphylococci.

Clark J, Fung-Tomc JC, Minassian B, Tsai YH, Yang H, Huczko E, Kolek B, Chaniewski S, Ferraro C, Drain R, Gradelski E, Bonner DP. Clark J, et al. Among authors: fung tomc jc. Antimicrob Agents Chemother. 2002 Apr;46(4):1108-11. doi: 10.1128/AAC.46.4.1108-1111.2002. Antimicrob Agents Chemother. 2002. PMID: 11897599 Free PMC article.

3

Bactericidal mechanism of gatifloxacin compared with other quinolones.

Gradelski E, Kolek B, Bonner D, Fung-Tomc J. Gradelski E, et al. J Antimicrob Chemother. 2002 Jan;49(1):185-8. doi: 10.1093/jac/49.1.185. J Antimicrob Chemother. 2002. PMID: 11751786

4

In vitro antifungal and fungicidal spectra of a new pradimicin derivative, BMS-181184.

Fung-Tomc JC, Minassian B, Huczko E, Kolek B, Bonner DP, Kessler RE. Fung-Tomc JC, et al. Antimicrob Agents Chemother. 1995 Feb;39(2):295-300. doi: 10.1128/AAC.39.2.295. Antimicrob Agents Chemother. 1995. PMID: 7726485 Free PMC article.

5

Antibacterial activities of cefprozil compared with those of 13 oral cephems and 3 macrolides.

Fung-Tomc JC, Huczko E, Stickle T, Minassian B, Kolek B, Denbleyker K, Bonner D, Kessler R. Fung-Tomc JC, et al. Antimicrob Agents Chemother. 1995 Feb;39(2):533-8. doi: 10.1128/AAC.39.2.533. Antimicrob Agents Chemother. 1995. PMID: 7726528 Free PMC article.

6

In vitro activity of a new oral triazole, BMS-207147 (ER-30346).

Fung-Tomc JC, Huczko E, Minassian B, Bonner DP. Fung-Tomc JC, et al. Antimicrob Agents Chemother. 1998 Feb;42(2):313-8. doi: 10.1128/AAC.42.2.313. Antimicrob Agents Chemother. 1998. PMID: 9527778 Free PMC article.

7

Comparative killing rates of fluoroquinolones and cell wall-active agents.

Fung-Tomc JC, Gradelski E, Valera L, Kolek B, Bonner DP. Fung-Tomc JC, et al. Antimicrob Agents Chemother. 2000 May;44(5):1377-80. doi: 10.1128/AAC.44.5.1377-1380.2000. Antimicrob Agents Chemother. 2000. PMID: 10770784 Free PMC article.

8

Antibacterial spectrum of a novel des-fluoro(6) quinolone, BMS-284756.

Fung-Tomc JC, Minassian B, Kolek B, Huczko E, Aleksunes L, Stickle T, Washo T, Gradelski E, Valera L, Bonner DP. Fung-Tomc JC, et al. Antimicrob Agents Chemother. 2000 Dec;44(12):3351-6. doi: 10.1128/AAC.44.12.3351-3356.2000. Antimicrob Agents Chemother. 2000. PMID: 11083639 Free PMC article.

9

Synergistic activity of the novel des-fluoro(6) quinolone, garenoxacin (BMS-284756), in combination with other antimicrobial agents against Pseudomonas aeruginosa and related species.

Fung-Tomc JC, Gradelski E, Valera L, Huczko E, Bonner DP. Fung-Tomc JC, et al. Int J Antimicrob Agents. 2002 Jul;20(1):57-60. doi: 10.1016/s0924-8579(02)00109-7. Int J Antimicrob Agents. 2002. PMID: 12127712

10

In vitro activities of cefepime alone and with amikacin against aminoglycoside-resistant gram-negative bacteria.

Fung-Tomc J, Huczko E, Kolek B, Thater C, Kessler RE. Fung-Tomc J, et al. Antimicrob Agents Chemother. 1991 Dec;35(12):2652-4. doi: 10.1128/AAC.35.12.2652. Antimicrob Agents Chemother. 1991. PMID: 1810203 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters